Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

GM mosquitoes may be used to prevent transmission of malaria

Steve Connor
Wednesday 22 May 2002 19:00 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Scientists have created a genetically modified (GM) mosquito that is almost incapable of transmitting malaria to humans. The development could lead to the release of GM mosquitoes into malaria regions to prevent transmission of one of the world's biggest killer diseases.

A team led by Marcelo Jacobs-Lorena, professor of genetics at Case Western Reserve University in Cleveland, Ohio, engineered a species of the Anopheles mosquito family that was unable to pass on the malaria parasite in its saliva when it bit.

In a study published in the journal Nature today, the scientists inserted a gene into the mosquito's DNA to produce a protein that blocked the complicated life-cycle of the malaria parasite, reducing its transmissibility to humans by 80 per cent.

Professor Jacobs-Lorena said the protein prevented the malaria parasite from moving from the gut of the mosquito, where it replicated, into the salivary glands, from where it was injected into the blood of a human victim.

Malaria affects between 300 million and 500 million people each year and kills an estimated 2 million, many of whom are children living in Africa. It cuts economic performance by 1.5 per cent in the worst-hit countries. Increased drug resistance and a failure of other forms of mosquito control, such as insecticides, had allowed the disease to make a comeback in many parts of the world, Professor Jacobs-Lorena said.

"I think the value of this research is that it will provide an extra weapon. Drugs and insecticides exist and help, but they are not very effective because of resistance," he said. Further work would be needed before GM insects were released into the wild. "No approach is 100 per cent effective 100 per cent of the time. The more varied tools we have, the better it is," he said.

The GM mosquito appeared to be as fit and fertile as its natural counterpart, so one possibility was to release it into a region that had recently been sprayed, allowing it to replace the wild, malaria-carrying population.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in